Page last updated: 2024-09-02

triptolide and Myelodysplastic Syndromes

triptolide has been researched along with Myelodysplastic Syndromes in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cen, JN; Gao, HQ; Hua, HY; Sun, AN; Wu, LL1
Deng, J; Jin, J1

Other Studies

2 other study(ies) available for triptolide and Myelodysplastic Syndromes

ArticleYear
Arsenic trioxide and triptolide synergistically induce apoptosis in the SKM‑1 human myelodysplastic syndrome cell line.
    Molecular medicine reports, 2016, Volume: 14, Issue:5

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Diterpenes; Drug Synergism; Epoxy Compounds; Gene Expression Regulation, Neoplastic; Humans; Myelodysplastic Syndromes; Oxides; Phenanthrenes; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species

2016
[Study of triptolide-induced apoptosis in MUTZ-1 cells and its allied mechanism].
    Zhongguo shi yan xue ye xue za zhi, 2005, Volume: 13, Issue:3

    Topics: Antineoplastic Agents, Alkylating; Apoptosis; Baculoviral IAP Repeat-Containing 3 Protein; Blotting, Western; Caspase 3; Cell Line; Diterpenes; Epoxy Compounds; Flow Cytometry; Gene Expression; Humans; Inhibitor of Apoptosis Proteins; Myelodysplastic Syndromes; Phenanthrenes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Ubiquitin-Protein Ligases

2005